Related references
Note: Only part of the references are listed.Meta-Regression to Identify Patients Deriving the Greatest Benefit from Dual Antiplatelet Therapy after Stroke or Transient Ischemic Attack Without Thrombolytic or Thrombectomy Treatment
Giuseppe Patti et al.
AMERICAN JOURNAL OF CARDIOLOGY (2019)
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y12 Receptor Inhibitor Treatment in Percutaneous Coronary Intervention
Dirk Sibbing et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2019)
A Genotype-Guided Strategy for Oral P2Y12 Inhibitors in Primary PCI
Daniel M. F. Claassens et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
'Ten commandments' for the 2018 ESC/EACTS Guidelines on Myocardial Revascularization
Franz-Josef Neumann et al.
EUROPEAN HEART JOURNAL (2019)
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Marco Valgimigli et al.
EUROPEAN HEART JOURNAL (2018)
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)
Victor Aboyans et al.
EUROPEAN HEART JOURNAL (2018)
Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization
Stefano Savonitto et al.
CIRCULATION (2018)
The paradox of clopidogrel use in patients with acute coronary syndromes and diabetes: insight from the Diabetes and Acute Coronary Syndrome Registry
Marco Ferlini et al.
CORONARY ARTERY DISEASE (2018)
Canadian Stroke Best Practice Recommendations for Acute Stroke Management: Prehospital, Emergency Department, and Acute Inpatient Stroke Care, 6th Edition, Update 2018
J. M. Boulanger et al.
INTERNATIONAL JOURNAL OF STROKE (2018)
Pharmacogenomic Approach to Selecting Antiplatelet Therapy in Patients With Acute Coronary Syndromes The PHARMCLO Trial
Francesca Maria Notarangelo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
Sonia S. Anand et al.
LANCET (2018)
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
S. Claiborne Johnston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study
Thomas Cuisset et al.
EUROPEAN HEART JOURNAL (2017)
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial
Dirk Sibbing et al.
LANCET (2017)
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease
J. W. Eikelboom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease
William R. Hiatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT
Paolo Zocca et al.
EUROINTERVENTION (2017)
Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registry
Maximilian Tscharre et al.
PLOS ONE (2017)
International Expert Consensus on Switching Platelet P2Y12 Receptor-Inhibiting Therapies
Dominick J. Angiolillo et al.
CIRCULATION (2017)
Advocating cardiovascular precision medicine with P2Y12 receptor inhibitors
Max-Paul Winter et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2017)
Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study
Usman Haber et al.
AMERICAN HEART JOURNAL (2017)
Switching P2Y(12)-receptor inhibitors in patients with coronary artery disease
Fabiana Rollini et al.
NATURE REVIEWS CARDIOLOGY (2016)
Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerations
Leonardo De Luca et al.
AMERICAN HEART JOURNAL (2016)
Management of Critical Limb Ischemia
Scott Kinlay
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2016)
The Role of Platelets in Cardiovascular Disease: Molecular Mechanisms
Angeliki Papapanagiotou et al.
CURRENT PHARMACEUTICAL DESIGN (2016)
Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry
Anders Sahlen et al.
EUROPEAN HEART JOURNAL (2016)
Clinical Value of CYP2C19 Genetic Testing for Guiding the Antiplatelet Therapy in a Chinese Population
De-Liang Shen et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2016)
Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease
Marc P. Bonaca et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease
Glenn N. Levine et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Contemporary antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: 1-year outcomes from the GReek AntiPlatElet (GRAPE) Registry
D. Alexopoulos et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
Platelet function monitoring to adjust antiplatelet therapy in elderly patients stented for an acute coronary syndrome (ANTARCTIC): an open-label, blinded-endpoint, randomised controlled superiority trial
Guillaume Cayla et al.
LANCET (2016)
Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials
Peter M. Rothwell et al.
LANCET (2016)
Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Nicholas J. Kassebaum et al.
LANCET (2016)
Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015
Haidong Wang et al.
LANCET (2016)
Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack
S. Claiborne Johnston et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Drug-Eluting or Bare-Metal Stents for Coronary Artery Disease
K. H. Bonaa et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Comparison of current platelet functional tests for the assessment of aspirin and clopidogrel response A review of the literature
Sandra Le Quellec et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)
Anders Sahlen et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2016)
P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries
Uwe Zeymer et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2016)
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries
Nicolas Danchin et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2016)
Contemporary Use of Ticagrelor in Interventional Practice (from Blue Cross Blue Shield of Michigan Cardiovascular Consortium)
Amrita M. Karve et al.
AMERICAN JOURNAL OF CARDIOLOGY (2015)
Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-up
Sami M. A. Alnasser et al.
AMERICAN JOURNAL OF MEDICINE (2015)
Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial One-Year Outcomes
Yilong Wang et al.
CIRCULATION (2015)
Building the Case for Clopidogrel as a World Health Organization Essential Medicine
Amisha Patel et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2015)
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention
Daniel Aradi et al.
EUROPEAN HEART JOURNAL (2015)
Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease A Patient-Level Pooled Analysis of 6,081 Patients
Raffaele Piccolo et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2015)
Long-Term Safety of Drug-Eluting and Bare-Metal Stents Evidence From a Comprehensive Network Meta-Analysis
Tullio Palmerini et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention
Philippe Genereux et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Marc P. Bonaca et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Building the Case for Clopidogrel as a World Health Organization Essential Medicine
Amisha Patel et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2015)
Novel antiplatelet agents in acute coronary syndrome
Francesco Franchi et al.
NATURE REVIEWS CARDIOLOGY (2015)
Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial
Manesh R. Patel et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2015)
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations
J. Wouter Jukema et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2015)
Treatment Patterns and Outcomes in Patients Undergoing Percutaneous Coronary Intervention Treated With Prasugrel or Clopidogrel (from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR])
Peter Damman et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Real-world observations with prasugrel compared to clopidogrel in acute coronary syndrome patients treated with percutaneous coronary intervention in the United States
Jay P. Bae et al.
CURRENT MEDICAL RESEARCH AND OPINION (2014)
2014 ESC/EACTS Guidelines on myocardial revascularization
Stephan Windecker et al.
EUROPEAN HEART JOURNAL (2014)
Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial
Clemens von Birgelen et al.
LANCET (2014)
Response Variability to P2Y12 Receptor Inhibitors Expectations and Reality
Jolanta M. Siller-Matula et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2013)
Consensus and Update on the Definition of On-Treatment Platelet Reactivity to Adenosine Diphosphate Associated With Ischemia and Bleeding
Udaya S. Tantry et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
F. Gerald R. Fowkes et al.
LANCET (2013)
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
Yongjun Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Mechanisms of Platelet Activation in Acute Coronary Syndromes
Dimitrios A. Stakos et al.
Current Vascular Pharmacology (2012)
A Randomized Trial of Prasugrel Versus Clopidogrel in Patients With High Platelet Reactivity on Clopidogrel After Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stents Results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) Study
Dietmar Trenk et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
A Randomized Controlled Trial in Second-Generation Zotarolimus-Eluting Resolute Stents Versus Everolimus-Eluting Xience V Stents in Real-World Patients The TWENTE Trial
Clemens von Birgelen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Effects of Clopidogrel Added to Aspirin in Patients with Recent Lacunar Stroke
Oscar R. Benavente et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Bedside Monitoring to Adjust Antiplatelet Therapy for Coronary Stenting
Jean-Philippe Collet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Randomized comparison of platelet function monitoring to adjust antiplatelet therapy versus standard of care: Rationale and design of the Assessment with a double Randomization of (1) a fixed dose versus a monitoring-guided dose of aspirin and Clopidogrel after DES implantation, and (2) Treatment Interruption versus Continuation, 1 year after stenting (ARCTIC) study
Jean-Philippe Collet et al.
AMERICAN HEART JOURNAL (2011)
Usefulness of Platelet Response to Clopidogrel by Point-of-Care Testing to Predict Bleeding Outcomes in Patients Undergoing Percutaneous Coronary Intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study)
Giuseppe Patti et al.
AMERICAN JOURNAL OF CARDIOLOGY (2011)
Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention The GRAVITAS Randomized Trial
Matthew J. Price et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Clopidogrel-Drug Interactions
Eric R. Bates et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Genomic Medicine Genomics and Drug Response
Liewei Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Comparative Determinants of 4-Year Cardiovascular Event Rates in Stable Outpatients at Risk of or With Atherothrombosis
Deepak L. Bhatt et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Rapid Evaluation after High-Risk TIA is Associated with Lower Stroke Risk
Caren M. Wu et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2009)
Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease The ONSET/OFFSET Study
Paul A. Gurbel et al.
CIRCULATION (2009)
Patients with peripheral arterial disease in the CHARISMA trial
Patrice P. Cacoub et al.
EUROPEAN HEART JOURNAL (2009)
Aspirin for the Prevention of Cardiovascular Events in Patients With Peripheral Artery Disease A Meta-analysis of Randomized Trials
Jeffrey S. Berger et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
S. J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prasugrel achieves greater and faster P2Y(12) receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease
Lars Wallentin et al.
EUROPEAN HEART JOURNAL (2008)
Early risk of stroke after transient ischemic attack - A systematic review and meta-analysis
Caren M. Wu et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis
Matthew F. Giles et al.
LANCET NEUROLOGY (2007)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison
Peter M. Rothwell et al.
LANCET (2007)
Adhesion mechanisms in platelet function
Zaverio M. Ruggeri et al.
CIRCULATION RESEARCH (2007)
Cost-effectiveness of clopidogrel in myocardial infarction with ST-segment elevation:: A European model based on the CLARITY and COMMIT trials
Jenny Berg et al.
CLINICAL THERAPEUTICS (2007)
The association of post-stroke neurological improvement with risk of subsequent deterioration due to stroke events
S. Aslanyan et al.
EUROPEAN JOURNAL OF NEUROLOGY (2007)
Inter-society consensus for the management of peripheral arterial disease (TASC II)
L. Norgren et al.
JOURNAL OF VASCULAR SURGERY (2007)
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
DL Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention - Results from The Clopidogrel for the Reduction of Events During Observation (CREDO) trial
SC Beinart et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention - Results from the ARMYDA-2 (Antiplatelet therapy for reduction of MYocardial Damage during Angioplasty) study
G Patti et al.
CIRCULATION (2005)
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
HC Diener et al.
LANCET (2004)
The high risk of stroke immediately after transient ischemic attack - A population-based study
MD Hill et al.
NEUROLOGY (2004)
Early recovery after cerebral ischemia risk of subsequent neurological deterioration
SC Johnston et al.
ANNALS OF NEUROLOGY (2003)
Are patients with acutely recovered cerebral ischemia more unstable?
SC Johnston et al.
STROKE (2003)
Peripheral arterial disease - epidemiological aspects
MH Criqui
VASCULAR MEDICINE (2001)
Identification and biological activity of the active metabolite of clopidogrel
P Savi et al.
THROMBOSIS AND HAEMOSTASIS (2000)
Share Paper
